Kereviz

Bitki adı:Celery, leaves, root, seeds
Bilimsel adı:Apium graveolens
Cins:Apium
Familya:Apiaceae
Diğer adları:Celery s

KEREVİZ (Yabanî)-Âpium graveoiens L. (Umbelliferae). 30-100 cm yükseklikte, parçalı yapraklı, beyaz çiçekli, iki yıllık ve otsu bir bitkidir. Yumru kökü olan bir formu Türkiye’de yetiştirilir ve sebze olarak kullanılır. Bk. Yabanî kereviz. Âpium nodifiorum (L.) Lag.-Çok yıllık ve otsu bir bitkidir. Genç yapraklan Diyarbakır ve Siverek (Urfa) pazarlannda Bendik adı altında satılır ve sebze olarak kullanılır. Batı Anadolu (Marmaris-Muğla) bölgesinde bu bitkiye Tatlı gerdeme adı verilmektedir.[Türkçe Bitki Adları Sözlüğü, Turhan Baytop, 2007]


Apium graveolens

Genel Bilgiler


Duke – Ethnobotany

Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb20: 23
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Brutus
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke

Bilimsel Araştırmalar

Studies in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and Amyotrophic lateral sclerosis, Huntington's disease, and so on, have suggested that inflammation is not only a result of neurodegeneration but also a crucial player in this process. Protein aggregates which are very common pathological phenomenon in neurodegeneration can induce neuroinflammation which further aggravates protein aggregation and neurodegeneration. Actually, inflammation even happens earlier than protein aggregation. Neuroinflammation induced by genetic variations in CNS cells or by peripheral immune cells may induce protein deposition in some susceptible population. Numerous signaling pathways and a range of CNS cells have been suggested to be involved in the pathogenesis of neurodegeneration, although they are still far from being completely understood. Due to the limited success of traditional treatment methods, blocking or enhancing inflammatory signaling pathways involved in neurodegeneration are considered to be promising strategies for the therapy of neurodegenerative diseases, and many of them have got exciting results in animal models or clinical trials. Some of them, although very few, have been approved by FDA for clinical usage. Here we comprehensively review the factors affecting neuroinflammation and the major inflammatory signaling pathways involved in the pathogenicity of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral sclerosis. We also summarize the current strategies, both in animal models and in the clinic, for the treatment of neurodegenerative diseases.

Makaleyi görüntüle
The European Commission asked EFSA for a scientific evaluation on the risks to human health related to the presence of perfluoroalkyl substances (PFASs) in food. Based on several similar effects in animals, toxicokinetics and observed concentrations in human blood, the CONTAM Panel decided to perform the assessment for the sum of four PFASs: PFOA, PFNA, PFHxS and PFOS. These made up half of the lower bound (LB) exposure to those PFASs with available occurrence data, the remaining contribution being primarily from PFASs with short half-lives. Equal potencies were assumed for the four PFASs included in the assessment. The mean LB exposure in adolescents and adult age groups ranged from 3 to 22, the 95th percentile from 9 to 70 ng/kg body weight (bw) per week. Toddlers and 'other children' showed a twofold higher exposure. Upper bound exposure was 4- to 49-fold higher than LB levels, but the latter were considered more reliable. 'Fish meat', 'Fruit and fruit products' and 'Eggs and egg products' contributed most to the exposure. Based on available studies in animals and humans, effects on the immune system were considered the most critical for the risk assessment. From a human study, a lowest BMDL 10 of 17.5 ng/mL for the sum of the four PFASs in serum was identified for 1-year-old children. Using PBPK modelling, this serum level of 17.5 ng/mL in children was estimated to correspond to long-term maternal exposure of 0.63 ng/kg bw per day. Since accumulation over time is important, a tolerable weekly intake (TWI) of 4.4 ng/kg bw per week was established. This TWI also protects against other potential adverse effects observed in humans. Based on the estimated LB exposure, but also reported serum levels, the CONTAM Panel concluded that parts of the European population exceed this TWI, which is of concern.

Makaleyi görüntüle
Background Atherosclerosis is the major cause of morbidities and mortalities worldwide. In this study we aimed to review the mechanism of atherosclerosis and its risk factors, focusing on new findings in atherosclerosis markers and its risk factors. Furthermore, the role of antioxidants and medicinal herbs in atherosclerosis and endothelial damage has been discussed and a list of important medicinal plants effective in the treatment and prevention of hyperlipidemia and atherosclerosis is presented. Methods The recently published papers about atherosclerosis pathogenesis and herbal medicines effective in the treatment and prevention of hyperlipidemia and atherosclerosis were searched. Results Inflammation has a crucial role in pathogenesis of atherosclerosis. The disease is accompanied by excessive fibrosis of the intima, fatty plaques formation, proliferation of smooth muscle cells, and migration of a group of cells such as monocytes, T cells, and platelets which are formed in response to inflammation. The oxidation of low density lipoprotein (LDL) to Ox-LDL indicates the first step of atherosclerosis in cardiovascular diseases. Malondialdehyde factor shows the level of lipoperoxidation and is a sign of increased oxidative pressure and cardiovascular diseases. In special pathological conditions such as severe hypercholesterolemia, peroxynitrite concentration increases and atherosclerosis and vascular damage are intensified. Medicinal plants have shown to be capable of interacting these or other pathogenesis factors to prevent atherosclerosis. Conclusions The pathogenesis factors involved in atherosclerosis have recently been cleared and the discovery of these factors has brought about new hopes for better prevention and treatment of atherosclerosis.

Makaleyi görüntüle
Human intervention trials have provided evidence for protective effects of various (poly)phenol-rich foods against chronic disease, including cardiovascular disease, neurodegeneration, and cancer. While there are considerable data suggesting benefits of (poly)phenol intake, conclusions regarding their preventive potential remain unresolved due to several limitations in existing studies. Bioactivity investigations using cell lines have made an extensive use of both (poly)phenolic aglycones and sugar conjugates, these being the typical forms that exist in planta, at concentrations in the low-μM-to-mM range. However, after ingestion, dietary (poly)phenolics appear in the circulatory system not as the parent compounds, but as phase II metabolites, and their presence in plasma after dietary intake rarely exceeds nM concentrations. Substantial quantities of both the parent compounds and their metabolites pass to the colon where they are degraded by the action of the local microbiota, giving rise principally to small phenolic acid and aromatic catabolites that are absorbed into the circulatory system. This comprehensive review describes the different groups of compounds that have been reported to be involved in human nutrition, their fate in the body as they pass through the gastrointestinal tract and are absorbed into the circulatory system, the evidence of their impact on human chronic diseases, and the possible mechanisms of action through which (poly)phenol metabolites and catabolites may exert these protective actions. It is concluded that better performed in vivo intervention and in vitro mechanistic studies are needed to fully understand how these molecules interact with human physiological and pathological processes.

Makaleyi görüntüle
Plants respond to herbivory through various morphological, biochemicals, and molecular mechanisms to counter/offset the effects of herbivore attack. The biochemical mechanisms of defense against the herbivores are wide-ranging, highly dynamic, and are mediated both by direct and indirect defenses. The defensive compounds are either produced constitutively or in response to plant damage, and affect feeding, growth, and survival of herbivores. In addition, plants also release volatile organic compounds that attract the natural enemies of the herbivores. These strategies either act independently or in conjunction with each other. However, our understanding of these defensive mechanisms is still limited. Induced resistance could be exploited as an important tool for the pest management to minimize the amounts of insecticides used for pest control. Host plant resistance to insects, particularly, induced resistance, can also be manipulated with the use of chemical elicitors of secondary metabolites, which confer resistance to insects. By understanding the mechanisms of induced resistance, we can predict the herbivores that are likely to be affected by induced responses. The elicitors of induced responses can be sprayed on crop plants to build up the natural defense system against damage caused by herbivores. The induced responses can also be engineered genetically, so that the defensive compounds are constitutively produced in plants against are challenged by the herbivory. Induced resistance can be exploited for developing crop cultivars, which readily produce the inducible response upon mild infestation, and can act as one of components of integrated pest management for sustainable crop production.

Makaleyi görüntüle

Kaynaklar ve Görseller

«Aphyllocladus DenticulatusApocynum androsaemifolium»